Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 20.

Periodontal Disease in Rheumatoid ArthritisPeriodontal Disease in Rheumatoid Arthritis
A study finding that periodontal disease is associated with RA considers the interesting question of whether the periodontal region, like the joints, are targeted by the autoimmune process. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 9, 2014 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news

Immune system component found that resists sepsis in mice
Mice lacking a specific component of the immune system are completely resistant to sepsis, a potentially fatal complication of infection, molecular microbiologists report. The discovery suggests that blocking this immune system component may help reduce inflammation in human autoimmune and hyper-inflammatory diseases such as rheumatoid arthritis and Type 2 diabetes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 9, 2014 Category: Science Source Type: news

Low-Dose Rituxan OK for RA Retreatment
(MedPage Today) -- Halving the dose of rituximab when retreatment is needed may offer an effective long-term option for disease control in rheumatoid arthritis, a randomized trial suggested. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 8, 2014 Category: Geriatrics Source Type: news

Rheuminations: Stem Cells in RA?
(MedPage Today) -- Could stem cell therapy be a breakthrough in rheumatoid arthritis? Belgian company TiGenix thinks so. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 6, 2014 Category: Geriatrics Source Type: news

Patient died during drug trial 'because of multiple organ failure'
Heather Valerie Owen, 62, suffered chest pains, fever and shortness of breath after taking a new drug for rheumatoid arthritis for seven weeks (Source: Telegraph Health)
Source: Telegraph Health - July 4, 2014 Category: Consumer Health News Tags: drug trial death multiple organ failure Heather Valerie Owen Source Type: news

Rheumatoid arthritis: Is exercise important?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - July 4, 2014 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: Protect your health with vaccines
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - July 4, 2014 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: Is exercise important?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - July 4, 2014 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: Protect your health with vaccines
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - July 4, 2014 Category: Consumer Health News Source Type: news

From Paris, New Data on Treating Rheumatoid ArthritisFrom Paris, New Data on Treating Rheumatoid Arthritis
Dr. Michael Schiff discusses new data on the role of that old standby in RA, methotrexate, plus other new treatment advances. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2014 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

Lung Disease in RA Common, Lethal
(MedPage Today) -- Patients with rheumatoid arthritis-associated interstitial lung disease tend to have a distinct clinical phenotype that includes older age, respiratory symptoms, and worse RA overall -- and are at substantial risk for early mortality, researchers reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 2, 2014 Category: Primary Care Source Type: news

Pregnancy: Effects of Active RA Seen in Offspring
(MedPage Today) -- Almost one-third of babies born to women with active rheumatoid arthritis experience rapid catch-up growth early in life, which places them at risk for later health problems, Dutch researchers warned. (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - July 2, 2014 Category: OBGYN Source Type: news

Thunder God Vine for Pain?
I have rheumatoid arthritis and have been told that a Chinese herb, thunder god vine, works better than prescription medication for pain. Would this be a worthwhile treatment for me? (Source: Dr. Weil Q and A)
Source: Dr. Weil Q and A - June 30, 2014 Category: Consumer Health News Source Type: news

Infection Risks Similar With RA Biologics
(MedPage Today) -- The risks of serious infections among patients with rheumatoid arthritis treated with anti-tumor necrosis factor agents were similar to those for patients given other types of biologics, a retrospective cohort study showed. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 30, 2014 Category: Geriatrics Source Type: news

Some aggressive cancers may respond to anti-inflammatory drugs
Some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis, new research suggests. Studying triple-negative breast cancer, researchers found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 27, 2014 Category: Science Source Type: news

Some aggressive cancers may respond to anti-inflammatory drugs
(Washington University School of Medicine) New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 27, 2014 Category: Cancer & Oncology Source Type: news

“Some Aggressive Cancers May Respond to Anti-inflammatory Drugs,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Studying triple-negative breast cancer, researchers at the Siteman Cancer Center and Washington University School of Medicine found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is one of the 25 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - June 27, 2014 Category: Cancer & Oncology Source Type: news

Rheumatoid Arthritis - Remicade
Rheumatoid Arthritis - My Doctor Says I Need Remicade (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 25, 2014 Category: Journals (General) Source Type: news

Durable Drug-Free Remission Possible for RADurable Drug-Free Remission Possible for RA
Some adults with active rheumatoid arthritis (RA) achieved drug-free remission at 12 months after first-line treatment with abatacept, and a proportion remained drug-free up to 18 months. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

RHEUMATOID ARTHRITIS NOSODE (Atp (Adenosine Triphosphate Disodium), Malic Acid, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Apiolum, Cinnamic Acid, Dhea (Dehydroepiandrosterone),) Liquid [Deseret Biologicals, Inc.]
Updated Date: Jun 23, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - June 23, 2014 Category: Drugs & Pharmacology Source Type: news

Rheuminations: Chinese Herb for RA Questioned
(MedPage Today) -- MedPage Today recently reported on a randomized study conducted in China in which a plant extract widely used in traditional Chinese medicine was found to be noninferior to methotrexate in patients with rheumatoid arthritis, but not everyone agrees that the herbal extract is safe. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 20, 2014 Category: Geriatrics Source Type: news

Methotrexate Use Falls Short in RA
Methotrexate (MedPage Today) -- the inexpensive anchor drug for the treatment of rheumatoid arthritis -- isn't being used optimally today, with few patients switching from the oral to the subcutaneous formulation, researchers found. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 19, 2014 Category: Geriatrics Source Type: news

Teen's struggle with 'old person's' disease: 'I had rheumatoid arthritis at 16'
DISTRESSED Heather Edwards was struggling to walk, kneel down or extend her elbows when she was diagnosed with the autoimmune disease - aged just 16 (Source: Daily Express - Health)
Source: Daily Express - Health - June 19, 2014 Category: Consumer Health News Source Type: news

Juvenile rheumatoid arthritis: What are the symptoms?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 19, 2014 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: What causes it?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 19, 2014 Category: Consumer Health News Source Type: news

Juvenile rheumatoid arthritis: What are the symptoms?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 19, 2014 Category: Consumer Health News Source Type: news

Rheumatoid arthritis: What causes it?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - June 19, 2014 Category: Consumer Health News Source Type: news

New Tool Will Pinpoint CVD Risk in Arthritis
PARIS (MedPage Today) -- Researchers from around the world are collaborating on a cardiovascular disease risk calculator specific for rheumatoid arthritis to help clinicians more accurately assess risk among these patients. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 18, 2014 Category: Cardiology Source Type: news

EULAR: What's in the Pipeline for RA? (CME/CE)
PARIS (MedPage Today) -- In a popular poster session at the annual European Congress of Rheumatology, investigators from around the world reported on trials of investigational treatments for rheumatoid arthritis (RA) -- some successful, some not so. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 17, 2014 Category: Geriatrics Source Type: news

Sanofi and Regeneron report positive results from Phase III rheumatoid arthritis trial of sarilumab
French drug maker Sanofi and US-based Regeneron Pharmaceuticals have released positive results from a Phase III trial of investigational drug sarilumab in rheumatoid arthritis (RA) patients who were inadequate responders to methotrexate (MTX) therapy… (Source: Drug Development Technology)
Source: Drug Development Technology - June 15, 2014 Category: Pharmaceuticals Source Type: news

Oral RA Drug Shows Enduring Safety Results
PARIS (MedPage Today) -- The pattern of serious adverse events with tofacitinib treatment for rheumatoid arthritis (RA) has remained stable over time and has not increased in patients with long exposure to the drug, an integrated safety analysis showed. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 15, 2014 Category: Geriatrics Source Type: news

Combo Therapy Boosts Patient Outcomes in RA
PARIS (MedPage Today) -- Early rheumatoid arthritis (RA) patients with who had not previously received methotrexate fared significantly better if given a combination of tocilizumab and methotrexate than if they received either agent alone, according to researchers here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - June 14, 2014 Category: Journals (General) Source Type: news

Success in RA Seen with JAK-3 Inhibitor
PARIS (MedPage Today) -- A selective oral Janus kinase-3 inhibitor provided significant improvements in rheumatoid arthritis in a 6-month phase IIb study, an investigator reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - June 14, 2014 Category: Journals (General) Source Type: news

More Disease Activity in Obese Rheumatoid Arthritis PatientsMore Disease Activity in Obese Rheumatoid Arthritis Patients
The higher levels of disease activity could lead to more aggressive treatment, explaining why obese patients have less radiologic joint progression, new research suggests. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Promising Results With Sarilumab in Rheumatoid ArthritisPromising Results With Sarilumab in Rheumatoid Arthritis
The IL-6-receptor inhibitor sarilumab was superior to placebo when added to methotrexate in a phase 3 registration trial of patients with moderate to severe rheumatoid arthritis. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Gene Variants Predict Severity, Response in RA
PARIS--Allele variants at three new positions on the HLA-DRB1 gene helped predict disease severity and response to treatment in rheumatoid arthritis, a researcher reported here. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - June 13, 2014 Category: Rheumatology Source Type: news

Biosimilars in Rheumatoid Arthritis: Wave of the Future?Biosimilars in Rheumatoid Arthritis: Wave of the Future?
The biosimilars of etanercept and infliximab are equivalent to their respective reference biologics, new research shows, but the jury is still out on how big an impact biosimilars will have. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 13, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Genotyping can predict disease outcomes in rheumatoid arthritis patients
New cohort studies have shown the amino acid valine at position 11 of HLA-DRB1 gene to be the strongest independent genetic determinant of radiological damage in rheumatoid arthritis. In addition, positions 71 and 74 were found to represent independent predictors, with the three positions together: 11, 71 and 74 strongly associated with disease outcomes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 13, 2014 Category: Science Source Type: news

Genotyping can predict disease outcomes in rheumatoid arthritis patients
(European League Against Rheumatism) New cohort studies presented today at the European League Against Rheumatism Annual Congress have shown the amino acid valine at position 11 of HLA-DRB1 gene to be the strongest independent genetic determinant of radiological damage in rheumatoid arthritis. In addition, positions 71 and 74 were found to represent independent predictors, with the three positions together: 11, 71 and 74 strongly associated with disease outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2014 Category: Global & Universal Source Type: news

Biosimilars for RA Succeed in Phase III
PARIS (MedPage Today) -- Two antitumor necrosis factor blockers that were biosimilar to the proprietary agents etanercept (Enbrel) and infliximab (Remicade) were equivalent in efficacy to the original biologic formulations in patients with active rheumatoid arthritis, phase III trials demonstrated. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 12, 2014 Category: Geriatrics Source Type: news

Orencia Combo Tops in Early, Severe RA
PARIS (MedPage Today) -- In a study of patients with poor-prognosis early rheumatoid arthritis, more patients treated with abatacept (Orencia) plus methotrexate were in remission at 1 year than were those on methotrexate alone, a researcher reported here. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 12, 2014 Category: Geriatrics Source Type: news

New IL-6R Antibody Shows High RA Responses
PARIS--A monoclonal antibody directed against the interleukin (IL)-6 receptor alpha subunit provided a high level of clinical response among patients with moderate-to-severe rheumatoid arthritis, a researcher said here. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 12, 2014 Category: Geriatrics Source Type: news

Potential anti-TNF response biomarker identified
DNA methylation has been identified as a potential biomarker of response to etanercept and adalimumab in patients with rheumatoid arthritis according to preliminary results from one of the largest methylome-wide investigations of treatment response to anti-TNF therapies. This data bring clinicians a step closer to being able to personalize a patient's treatment pathway. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 12, 2014 Category: Science Source Type: news

Potential anti-TNF response biomarker identified
(European League Against Rheumatism) DNA methylation has been identified as a potential biomarker of response to etanercept and adalimumab in patients with rheumatoid arthritis according to preliminary results from one of the largest methylome-wide investigations of treatment response to anti-TNF therapies. This data, presented today at the European League Against Rheumatism Annual Congress, bring clinicians a step closer to being able to personalise a patient's treatment pathway. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2014 Category: Global & Universal Source Type: news

Benaroya Research Institute scientists identify drivers of rheumatoid arthritis
(Immune Tolerance Network) Researchers at Benaroya Research Institute at Virginia Mason used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2014 Category: Global & Universal Source Type: news

International Team Creates Heart Disease Risk Tool Tailored to Rheumatoid Arthritis Patients
Method may shed light on how to better gauge heart health in lupus, other inflammatory diseases Rochester, Minn. — Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - June 11, 2014 Category: Hospital Management Source Type: news

Paid Rheumatoid Arthritis (RA) Clinical Trial Now Enrolling at Achieve...
Achieve is conducting a multicenter, randomized, single-dose study assessing the pharmacodynamic parameters of an experimental combination therapy in...(PRWeb June 10, 2014)Read the full story at http://www.prweb.com/releases/2014/06/prweb11925600.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 10, 2014 Category: Pharmaceuticals Source Type: news

Crescendo Bioscience to present multiple studies at 2014 EULAR Meeting
(Myriad Genetics, Inc.) Crescendo Bioscience will present data from clinical studies with its Vectra DA test at the European League Against Rheumatism Annual Meeting. Vectra DA is a quantitative multi-biomarker test to measure disease activity in patients with rheumatoid arthritis. The data demonstrate the clinical utility of Vectra DA in assessing the risk of future joint damage at multiple points in time and changes in the scores were associated with favorable response to both non-biologic and biologic therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2014 Category: Global & Universal Source Type: news

Etanercept Benefits Seem Limited in Early ArthritisEtanercept Benefits Seem Limited in Early Arthritis
In patients with early rheumatoid arthritis receiving treatment with methotrexate and prednisone (COBRA-light) or the same agents along with sulfasalazine (COBRA), adding etanercept is not of notable benefit. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 3, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Business Briefing: F.D.A. Approves Celebrex in Generic Versions
The blockbuster drug, known generically as celecoxib, is used to treat pain, rheumatoid arthritis, osteoarthritis and other conditions. (Source: NYT Health)
Source: NYT Health - May 30, 2014 Category: Consumer Health News Authors: By THE ASSOCIATED PRESS Tags: Celebrex (Drug) Pfizer Inc PFE NYSE Food and Drug Administration Generic Brands and Products Mylan Inc MYL NASDAQ Source Type: news